---
title: "Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026 | IART Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275310985.md"
description: "Integra LifeSciences Holdings Corporation (NASDAQ: IART) will release its fourth quarter and full year 2025 financial results on February 26, 2026, before the market opens. A conference call with management will follow at 8:30 a.m. ET, with a live webcast available on the company's investor website. Participants are encouraged to register in advance. A replay of the call will be accessible afterward."
datetime: "2026-02-09T03:35:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275310985.md)
  - [en](https://longbridge.com/en/news/275310985.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275310985.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275310985.md) | [繁體中文](https://longbridge.com/zh-HK/news/275310985.md)


# Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026 | IART Stock News

PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

**About Integra LifeSciences**

Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard products and solutions is trusted by healthcare professionals to improve patient outcomes. For the latest news and information about Integra and its products, please visit www.integralife.com.

**Investor Relations:**  
**Chris Ward**  
(609) 772-7736  
chris.ward@integralife.com

**Media Contact:**  
**Laurene Isip**  
(609) 208-8121  
laurene.isip@integralife.com

**Integra LifeSciences Holdings Corporation**

### Related Stocks

- [Integra LifeSciences Holdings Corporation (IART.US)](https://longbridge.com/en/quote/IART.US.md)

## Related News & Research

- [BUZZ-Integra falls on downbeat first-quarter profit outlook](https://longbridge.com/en/news/277081990.md)
- [Integra LifeSciences Reports Q4 Loss, Revenue Edges Down](https://longbridge.com/en/news/277030937.md)
- [TAT Technologies to Announce Fourth Quarter Financial Results on March 18 and Host Earnings Webcast on March 19 | TATT Stock News](https://longbridge.com/en/news/279090410.md)
- [Funko To Announce 2025 Fourth Quarter Financial Results and Host Video Webcast On Thursday, March 12, 2026 | FNKO Stock News](https://longbridge.com/en/news/277773662.md)
- [Integra LifeSciences (IART) Q3 Earnings Report Preview: What To Look For](https://longbridge.com/en/news/263203915.md)